Tevogen Bio Holdings
Financial ratios & Valuation

Historical Multiples (2021 – 2023)

2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-76.47281.19-27.32KN/A281.19
Price/Sales ratio
N/AN/AN/AN/AN/A
Price/Book Value ratio
-72.343.62-2.64KN/A3.62
Price/Cash Flow ratio
-226.12-5.75K-1.33KN/A-5.75K
Price/Free Cash Flow ratio
-221.51-1.78K-1.33KN/A-1.78K
Price/Earnings Growth ratio
N/A-2.19270.27N/A-2.19
Dividend Yield
N/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/A
Effective Tax Rate
62.71%-5.23%N/AN/A-5.23%
Return on Assets
-203.65%1.23%-0.39%N/A1.23%
Return On Equity
94.59%1.28%9.67%N/A1.28%
Return on Capital Employed
-66.06%-3.84%-0.06%N/A-3.84%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/A
Quick Ratio
10.730.780.11N/A0.78
Cash ratio
10.650.360.00N/A0.36
Days of Sales Outstanding
N/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
3.060.110.09N/A0.11
Debt Equity Ratio
-1.420.11-2.34N/A0.11
Long-term Debt to Capitalization
3.350.10N/AN/A0.10
Total Debt to Capitalization
3.350.101.74N/A0.10
Interest Coverage Ratio
N/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
-0.22-0.00-0.84N/A-0.00
Company Equity Multiplier
-0.461.04-24.48N/A1.04
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.023.221N/A3.22
Cash Flow Coverage Ratio
-0.22-0.00-0.84N/A-0.00
Short Term Coverage Ratio
N/AN/A-0.84N/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/A